Document Detail

Intraarterial infusion of urokinase in the treatment of acute pulmonary thromboembolism: preliminary observations.
MedLine Citation:
PMID:  6340446     Owner:  NLM     Status:  MEDLINE    
Eleven patients were treated for acute pulmonary thromboembolism by perfusion of urokinase in the main pulmonary artery for a period of 12 hr with angiographic control. Clinical and radiologic improvement was achieved in all patients except for one in whom an embolectomy was later performed. The complications were similar to those for intravenous urokinase treatment, the most frequent being hemorrhage.
J Barberena
Related Documents :
8447876 - Arterial emboli of the upper extremity presenting as ischemic heart disease: case repor...
21642076 - Mobile masses in the aortic arch in a patient with acute embolic event.
8557516 - Theoretical considerations and in vitro results for the development of percutaneous tra...
9786276 - Successful innominate thromboembolectomy of a paradoxic embolus.
24584906 - Right gastroepiploic artery arising from the dorsal pancreatic artery: a very rare anat...
12204746 - Intracardiac migration of nitinol trapease vena cava filter and paradoxical embolism.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  140     ISSN:  0361-803X     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  1983 May 
Date Detail:
Created Date:  1983-05-27     Completed Date:  1983-05-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  883-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Endopeptidases / therapeutic use*
Hemorrhage / chemically induced
Infusions, Intra-Arterial
Middle Aged
Pulmonary Artery / radiography
Pulmonary Embolism / drug therapy*
Urokinase-Type Plasminogen Activator / administration & dosage,  adverse effects,  therapeutic use*
Reg. No./Substance:
EC 3.4.-/Endopeptidases; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polyhydramnios associated with fetal limb abnormalities.
Next Document:  Traveler's diarrhea: update 1983.